Experts highlight key themes from the ASCO GI Cancers Symposium, including the growing role of AI and an increased emphasis on patient-centered decision-making.

Presenters shared their personal highlights of attending ASCO GI 2026. The 2026 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium showcased not only transformative ...

The first half of this year has been riddled with market volatility and geopolitical tension. But 2025’s American Society of Clinical Oncology conference largely isn’t reflecting that turmoil. In fact ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. In this episode of Meeting Mic, we bring you pearls and ...

Bispecific antibodies are one of the most active areas of cancer research, and pharmaceutical companies are busy striking deals to add them to their pipelines. One of the most talked about drugs at ...

When combined with the IDO1 inhibitor epacadostat, Keytruda (pembrolizumab), a PD-1 inhibitor, resulted in an overall response rate (ORR) of 35 percent in patients with advanced urothelial carcinoma, ...

HIGHLIGHTSResults from the Phase 2a ACCENT trial in pancreatic cancer have been presented at the specialist conference ASCO Gastrointestinal ...

The Company will host an in-person event for analysts and institutional investors on Sunday, June 1, 2025, at 6:30 p.m. CT during the 2025 ASCO Annual Meeting in Chicago, IL. The event will follow the ...

Every year when the American Society of Clinical Oncology (ASCO) annual meeting rolls around, thousands of healthcare stakeholders make their way to Chicago to evaluate the future of cancer care. The ...